Abstracts published ahead of the 2025 American Society of Clinical Oncology Annual Meeting found persistent ovarian cancer ...

The Pershing Square Foundation (the "Foundation") today announced that it has awarded $5.25M to seven groundbreaking scientists at five premier institutions. For over a decade, the Foundation has ...

Toon Van Gorp, MD, PhD, discusses the rationale behind and the findings from the phase 3 MIRASOL trial of mirvetuximab soravtansine in patients with folate receptor α–positive, platinum-resistant ...

This is the first diagnostic test specifically for symptomatic women, where no diagnostic currently exists, a gap that has ...

Drugmakers are turning to biomarkers, like folate receptor alpha, and even cell therapies to tackle this deadly cancer in new ...

"New discoveries are needed to find lifesaving treatments for ovarian cancer, a cancer that tragically still has a low survival rate. Equipping leading researchers around the globe with powerful ...